TipRanks
Advertisement
Advertisement

PLRZ Stock Latest News

Polyrizon Expands IP Moat With New U.S. Patent Filing for Intranasal Drug-Delivery Platform
Company AnnouncementsPolyrizon Expands IP Moat With New U.S. Patent Filing for Intranasal Drug-Delivery Platform
19d ago
6K
PLRZ
Polyrizon files U.S. patent application for mucoadhesive technology
PremiumThe Fly
Polyrizon files U.S. patent application for mucoadhesive technology
20d ago
PLRZ
Polyrizon Files First-Half 2026 Results Showing Higher Assets and Wider Loss
PremiumCompany Announcements
Polyrizon Files First-Half 2026 Results Showing Higher Assets and Wider Loss
26d ago
6K
PLRZ
Polyrizon enrolls first patient in U.S. study of NASARIX
PremiumThe Fly
Polyrizon enrolls first patient in U.S. study of NASARIX
1M ago
PLRZ
Polyrizon files to sell 404,166 ordinary shares for holders
PremiumThe Fly
Polyrizon files to sell 404,166 ordinary shares for holders
1M ago
PLRZ
Polyrizon Raises $4 Million in Registered Direct Offering and Private Placement
PremiumCompany AnnouncementsPolyrizon Raises $4 Million in Registered Direct Offering and Private Placement
2M ago
6K
PLRZ
Polyrizon Raises $4 Million in Registered Direct Offering and Private Placement
Premium
Company Announcements
Polyrizon Raises $4 Million in Registered Direct Offering and Private Placement
2M ago
6K
PLRZ
Polyrizon announces $4.0M registered direct offering
Premium
The Fly
Polyrizon announces $4.0M registered direct offering
2M ago
PLRZ
Polyrizon completes all five U.S. site contracts for Nasarix allergy study
PremiumThe Fly
Polyrizon completes all five U.S. site contracts for Nasarix allergy study
2M ago
PLRZ
Polyrizon Finalizes U.S. Clinical Site Network for NASARIX Allergy Study
PremiumCompany Announcements
Polyrizon Finalizes U.S. Clinical Site Network for NASARIX Allergy Study
2M ago
6K
PLRZ
Polyrizon completes clinical site network for NASARIX study
PremiumThe Fly
Polyrizon completes clinical site network for NASARIX study
2M ago
PLRZ
Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026
PremiumCompany Announcements
Polyrizon Shareholders Approve New Executive Compensation Policy on July 13, 2026
3M ago
6K
PLRZ
Polyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray
PremiumCompany AnnouncementsPolyrizon Clears Key Safety Milestone for NASARIX Allergy Nasal Spray
4M ago
6K
PLRZ
Morning Movers: Lindsay climbs following quarterly report
Premium
The Fly
Morning Movers: Lindsay climbs following quarterly report
4M ago
FC
TP
Polyrizon announces results from Nasarix biocompatibility evaluation program
Premium
The Fly
Polyrizon announces results from Nasarix biocompatibility evaluation program
4M ago
PLRZ
Polyrizon Wins Central IRB Nod for First NASARIX Allergy Blocker Trial
PremiumCompany Announcements
Polyrizon Wins Central IRB Nod for First NASARIX Allergy Blocker Trial
4M ago
6K
PLRZ
Polyrizon receives central IRB approval for Nasarix
PremiumThe Fly
Polyrizon receives central IRB approval for Nasarix
4M ago
PLRZ
Polyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery Patent
PremiumCompany Announcements
Polyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery Patent
4M ago
6K
PLRZ
Polyrizon gets patent for Trap & Target mucoadhesive polymer technology platform
PremiumThe Fly
Polyrizon gets patent for Trap & Target mucoadhesive polymer technology platform
4M ago
PLRZ
Polyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway
PremiumCompany AnnouncementsPolyrizon Launches Key Human Study to Advance NASARIX Allergy Blocker Toward FDA Pathway
4M ago
6K
PLRZ
Polyrizon Wins European Patent Publication for Mucoadhesive Nasal Drug Delivery Platform
Premium
Company Announcements
Polyrizon Wins European Patent Publication for Mucoadhesive Nasal Drug Delivery Platform
5M ago
6K
PLRZ
Polyrizon receives notice of European patent publication
Premium
The Fly
Polyrizon receives notice of European patent publication
5M ago
PLRZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >